SCHEMBL21940289

SCHEMBL21940289

CN(C)c1cc(CN)nnc1-c1cn(C)nc1C(F)(F)F

nearest known ligand 0.40

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 1/20 0.40
▸ WDR77 Q9BQA1 1/20 0.40
▸ CYP2C19 P33261 2/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ S1PR2 O95136 13/20 0.38
▸ ALDH1A1 P00352 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ CYP1A2 P05177 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ BRD4 O60885 1/20 0.34
▸ IDH1 O75874 1/20 0.33
▸ MBOAT4 Q96T53 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20606921 0.84 S1PR2 (0.49) PRMT5WDR77CYP2C19CYP3A4S1PR2
SCHEMBL21940575 0.83 S1PR2 (0.39) PRMT5WDR77CYP2C19CYP3A4S1PR2
Hydrochloric Acid SCHEMBL20606941 0.82 S1PR2 (0.48) PRMT5WDR77CYP2C19CYP3A4S1PR2
SCHEMBL21941072 0.81 S1PR2 (0.41) PRMT5WDR77CYP2C19CYP3A4S1PR2
SCHEMBL21819818 0.79 PRMT5 (0.39) PRMT5WDR77CYP2C19CYP3A4S1PR2
SCHEMBL21940579 0.78 S1PR2 (0.40) PRMT5WDR77CYP2C19CYP3A4S1PR2
SCHEMBL21940283 0.76 IDH1 (0.37) PRMT5WDR77CYP2C19CYP3A4S1PR2
SCHEMBL21941069 0.75 SOS1 (0.37) PRMT5WDR77CYP2C19CYP3A4S1PR2
SCHEMBL21940577 0.72 PRMT5 (0.45) PRMT5WDR77CYP2C19CYP3A4S1PR2
SCHEMBL21940515 0.69 S1PR2 (0.55) PRMT5WDR77CYP2C19CYP3A4S1PR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3423445-B1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROSIS GALAPAGOS NV (BE) 2020-04-01 — — EP disclosed
Send feedback